Literature DB >> 6460826

Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.

R S Fairchild, J L Kyner, N I Abdou.   

Abstract

We evaluated antigen-nonspecific (Con A) and antigen-specific (islet cell) activation of suppressor cell function in 11 IDD patients. Compared with healthy controls, IDD was associated with both antigen-specific (n = 11, p less than 0.01) and nonspecific (n = 6, p less than 0.03) suppressor cell hypofunction. The specific defect was not present in NIDD patients and correlated negatively with the duration of the disease (r = -0.6, p less than 0.05). No relationship was found between the degree of specific suppressor cell dysfunction and diabetic control as assessed by glycosylated hemoglobin, plasma glucose values, insulin-binding capacity, or C-peptide determinations. Plasma from IDD lacked anti-suppressor cell activity. Low levels of circulating immune complexes were detected in IDD patients whose disease duration was 1 month or less. Specific suppressor cell hypofunction and/or enhanced helper cell activity in early stages of IDD could be contributing to the formation of islet cell autoantibodies, immune complexes, islet cell injury, and the diabetic state.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6460826

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  15 in total

1.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

2.  The effect of zinc status on the immune function of diabetic rats.

Authors:  A D Mooradian; D C Norman; J E Morley
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 4.  Disordered cellular immunity in type I diabetes of man and the BB rat.

Authors:  J B Buse; R F Rowley; G S Eisenbarth
Journal:  Surv Immunol Res       Date:  1982

5.  Immunologic factors in pathogenesis and treatment of human and animal diabetes.

Authors:  A Naji; W K Silvers; S T Bartlett; J Francfort; C F Barker
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

6.  Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.

Authors:  A A Rossini; D Faustman; B A Woda; A A Like; I Szymanski; J P Mordes
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

Review 7.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

8.  Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.

Authors:  P MacKay; J Jacobson; A Rabinovitch
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

9.  Immune abnormalities in diabetic patients not requiring insulin at diagnosis.

Authors:  U Di Mario; W J Irvine; D Q Borsey; J L Kyner; J Weston; C Galfo
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

10.  Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells.

Authors:  T Maruyama; I Takei; I Matsuba; A Tsuruoka; M Taniyama; Y Ikeda; K Kataoka; M Abe; S Matsuki
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.